New hormonal treatment launched to help prevent miscarriage in early pregnancy
April 4, 2025Research and Development Besins Healthcare, Reproductive health, hormonal therapy, miscarriage, pregnancy
A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that …
Mehiläinen acquires Regina Maria and MediGroup, and welcomes Hellman & Friedman as new shareholder
April 4, 2025Business Services, Marketing Services CVC, Corporate, MediGroup, Mehilainen, Regina Maria, shareholders
Mehiläinen, a Finnish health and social care provider, has announced that it has agreed to acquire Regina Maria and MediGroup. …
Bristol Myers Squibb receives positive CHMP opinion for Opdivo treatment
April 4, 2025Research and Development CHMP, Oncology, bristol myers squibb, immunotherapy, lung cancer, opdivo
Bristol Myers Squibb (BMS) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for …
Curium Pharma announces acquisition of Monrol
April 3, 2025Manufacturing and Production, Research and Development Curium Pharma, Monrol, Oncology, acquisition, nuclear medicine, radiopharmaceutical products
Curium Pharma, a nuclear medicine company, has acquired Eczacıbaşı-Monrol Nuclear Products (Monrol), a nuclear medicine player. With facilities across Europe …
Enosium Life Science acquires RWEality
April 3, 2025Business Services, Consultancy Consultancy, Corporate, Enosium Life Sciences, RWEality, acquisition, life sciences, research and development
Enosium Life Science, which specialises in life sciences, has acquired RWEality, a consultancy focused on public policies, technology and healthcare …
Bend Bioscience adds commercial spray drying facility to Georgia site
April 3, 2025Manufacturing Services, Manufacturing and Production Bend Bioscience, CDMO, Devices, manufacturing, pharma
Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry granulation system at its facility …
GRI Bio announces two global patents granted for Europe and Japan
April 2, 2025Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent
GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …
Usama Dar appointed as chief product and technology officer at CluePoints
April 2, 2025Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development
CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dar’s …
Dupixent approved as first biologic medicine in Japan for COPD patients
April 2, 2025Research and Development COPD, Chronic Diseases, Regeneron, Sanofi, biotech, respiratory disease
The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment …
ADHD coach and breathwork experts to run workshop for ADHD management
April 2, 2025Design & Creative, Freelancers ADHD, Neurology, healthcare, mental health, nervous system
ADHD coach John Harrington and breathwork facilitator Martin O’Toole will collaborate on ‘Breathwork for ADHD and Beyond’, a breathwork-orientated session …
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial
April 1, 2025Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development
Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …
Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint
April 1, 2025Research and Development Corcept Therapeutics, Oncology, ovarian cancer, research and development
Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the company’s phase …
Secarna Pharmaceuticals to announce positive new data at cancer research conference
April 1, 2025Research and Development Oncology, Secarna Pharmaceuticals, oncology, research and development
Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …
Qfitlia approved by FDA to treat haemophilia A or B
March 31, 2025Research and Development FDA, Haematology, Sanofi, haemophilia, pharma
The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat …
Alfred Merz appointed as CEO of ProBioGen
March 31, 2025Manufacturing Services, Manufacturing and Production CEO, Pharmacy, ProBioGen, appointment, biotech
ProBioGen has announced the appointment of Alfred Merz as its chief executive officer (CEO), effective 1 April 2025. Merz, who …
Medidata launches programme to accelerate therapy delivery
March 31, 2025Market Research Medidata, Pharmacy, pharma, technology
Medidata has announced the launch of its Medidata Site Insights Program – a collection of initiatives intended to foster more …
Winners announced for 2025 PM Society Awards
March 31, 2025Industry Associations, Research and Development Pharmacy, awards, pharma industry, pm society
The pharma marketing and healthcare communications industry gathered for the 39th PM Society Awards on 14 March 2025, which celebrates …
FDA grants fast track designation to chlamydia vaccine candidate
March 28, 2025Research and Development FDA, Infections and infestations, Sanofi, chlamydia, vaccination
The US Food and Drug Association (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention …
Shane Olwill appointed as chief development officer at Asgard Therapeutics
March 28, 2025Business Services, Clinical Research Asgard Therapeutics, CDO, Oncology, appointment, immunology
Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo …
Gergely Sved appointed as CEO of Ellab
March 28, 2025Contract Sales Organisations, Sales and Marketing CEO, Ellab, Pharmacy, appointment, life sciences
Ellab has announced that it has appointed Gergely Sved as its new chief executive officer (CEO). The company provides validation, …
Latest content
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner
